Home > Insider Trading > Filing (0001209191-18-056048)

Filing Details

Accession Number:: 0001209191-18-056048
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-10-24 16:18:07
Reporting Period:: 2018-10-22

Accepted Time:: 2018-10-24 16:18:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1169245	Phasebio Pharmaceuticals Inc	PHAS	Pharmaceutical Preparations (2834)	030375697

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1208570	Jr B Kenneth Lee	C/O Hatteras Ventures 280 S. Mangum St., Suite 350 Durham NC 27701	No	No	Yes	No
1219890	Alexander Robert Ingram	C/O Hatteras Ventures 280 S. Mangum St., Suite 350 Durham NC 27701	No	No	Yes	No
1291262	Md Douglas Reed	C/O Hatteras Ventures 280 S. Mangum St., Suite 350 Durham NC 27701	No	No	Yes	No
1390733	Hatteras Ventures Partners Iii Lp	C/O Hatteras Ventures 280 S. Mangum St., Suite 350 Durham NC 27701	No	No	Yes	No
1390738	Hatteras Venture Affiliates Iii Lp	C/O Hatteras Ventures 280 S. Mangum St., Suite 350 Durham NC 27701	No	No	Yes	No
1674107	John Crumpler	C/O Hatteras Ventures 280 S. Mangum St., Suite 350 Durham NC 27701	No	No	Yes	No
1674177	Hatteras Venture Advisors Iii, Llc	280 S. Mangum St., Suite 350 Durham NC 27701	No	No	Yes	No
1756148	Fund Multiplier Capital Venture	C/O Hatteras Ventures 280 S. Mangum St., Suite 350 Durham NC 27701	No	No	Yes	No
1756231	Hatteras Venture Partners I, Lp	C/O Hatteras Ventures 280 S. Mangum St., Suite 350 Durham NC 27701	No	No	Yes	No
1756233	Catalysta Ventures, Llc	C/O Hatteras Ventures 280 S. Mangum St., Suite 350 Durham NC 27701	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-10-22	52,690	$0.00	52,690	No	4	C	Indirect	By Hatteras Venture Partners I, LP
Common Stock	Acquisiton	2018-10-22	1,683,420	$0.00	1,683,420	No	4	C	Indirect	By Hatteras Venture Partners III, LP
Common Stock	Acquisiton	2018-10-22	137,513	$5.00	1,820,933	No	4	P	Indirect	By Hatteras Venture Partners III, LP
Common Stock	Acquisiton	2018-10-22	150,612	$0.00	150,612	No	4	C	Indirect	By Hatteras Venture Affiliates III, LP
Common Stock	Acquisiton	2018-10-22	12,487	$5.00	163,099	No	4	P	Indirect	By Hatteras Venture Affiliates III, LP
Common Stock	Acquisiton	2018-10-22	4,846	$0.00	4,846	No	4	C	Indirect	By Catalysta Ventures, LLC
Common Stock	Acquisiton	2018-10-22	266,481	$0.00	266,481	No	4	C	Indirect	By Venture Capital Multiplier Fund
Common Stock	Acquisiton	2018-10-22	150,000	$5.00	416,481	No	4	P	Indirect	By Venture Capital Multiplier Fund

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By Hatteras Venture Partners I, LP
No	4	C	Indirect	By Hatteras Venture Partners III, LP
No	4	P	Indirect	By Hatteras Venture Partners III, LP
No	4	C	Indirect	By Hatteras Venture Affiliates III, LP
No	4	P	Indirect	By Hatteras Venture Affiliates III, LP
No	4	C	Indirect	By Catalysta Ventures, LLC
No	4	C	Indirect	By Venture Capital Multiplier Fund
No	4	P	Indirect	By Venture Capital Multiplier Fund

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Series B Preferred Stock	Warrants to Purchase Series B Preferred Stock	Disposition	2018-10-22	19,061	$0.00	19,061	$0.12
Common Stock	Series B Preferred Stock	Acquisiton	2018-10-22	19,061	$0.12	19,061	$0.00
Common Stock	Series B Preferred Stock	Disposition	2018-10-22	458	$5.00	458	$0.00
Series B Preferred Stock	Warrants to Purchase Series B Preferred Stock	Disposition	2018-10-22	1,731	$0.00	1,731	$0.12
Common Stock	Series B Preferred Stock	Acquisiton	2018-10-22	1,731	$0.12	1,731	$0.00
Common Stock	Series B Preferred Stock	Disposition	2018-10-22	42	$5.00	42	$0.00
Series C-1 Preferred Stock	Warrants to Purchase Series C-1 Preferred Stock	Disposition	2018-10-22	47,458	$0.00	47,458	$0.12
Common Stock	Series C-1 Preferred Stock	Acquisiton	2018-10-22	47,458	$0.12	47,458	$0.00
Common Stock	Series C-1 Preferred Stock	Disposition	2018-10-22	1,139	$5.00	1,139	$0.00
Series C-1 Preferred Stock	Warrants to Purchase Series C-1 Preferred Stock	Disposition	2018-10-22	4,309	$0.00	4,309	$0.12
Common Stock	Series C-1 Preferred Stock	Acquisiton	2018-10-22	4,309	$0.12	4,309	$0.00
Common Stock	Series C-1 Preferred Stock	Disposition	2018-10-22	104	$5.00	104	$0.00
Series C-1 Preferred Stock	Warrants to Purchase Series C-1 Preferred Stock	Disposition	2018-10-22	41,414	$0.00	41,414	$0.12
Common Stock	Series C-1 Preferred Stock	Acquisiton	2018-10-22	41,414	$0.12	41,414	$0.00
Common Stock	Series C-1 Preferred Stock	Disposition	2018-10-22	994	$5.00	994	$0.00
Common Stock	Series 1 Preferred Stock	Disposition	2018-10-22	52,690	$0.00	52,690	$0.00
Common Stock	Series 1 Preferred Stock	Disposition	2018-10-22	42,530	$0.00	42,530	$0.00
Common Stock	Series 1 Preferred Stock	Disposition	2018-10-22	3,862	$0.00	3,862	$0.00
Common Stock	Series 1 Preferred Stock	Disposition	2018-10-22	4,846	$0.00	4,846	$0.00
Common Stock	Series AA Preferred Stock	Disposition	2018-10-22	174,699	$0.00	174,699	$0.00
Common Stock	Series AA Preferred Stock	Disposition	2018-10-22	13,609	$0.00	13,609	$0.00
Common Stock	Series B Preferred Stock	Disposition	2018-10-22	1,044,764	$0.00	1,044,764	$0.00
Common Stock	Series B Preferred Stock	Disposition	2018-10-22	94,874	$0.00	94,874	$0.00
Common Stock	Series C-1 Preferred Stock	Disposition	2018-10-22	149,320	$0.00	149,320	$0.00
Common Stock	Series C-1 Preferred Stock	Disposition	2018-10-22	13,558	$0.00	13,558	$0.00
Common Stock	Series C-1 Preferred Stock	Disposition	2018-10-22	40,420	$0.00	40,420	$0.00
Common Stock	Series D Preferred Stock	Disposition	2018-10-22	272,107	$0.00	272,107	$0.00
Common Stock	Series D Preferred Stock	Disposition	2018-10-22	24,709	$0.00	24,709	$0.00
Common Stock	Series D Preferred Stock	Disposition	2018-10-22	226,061	$0.00	226,061	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	No	4	X	Indirect
1,045,222	No	4	X	Indirect
1,044,764	No	4	S	Indirect
0	No	4	X	Indirect
94,916	No	4	X	Indirect
94,874	No	4	S	Indirect
0	No	4	X	Indirect
150,459	No	4	X	Indirect
149,320	No	4	S	Indirect
0	No	4	X	Indirect
13,662	No	4	X	Indirect
13,558	No	4	S	Indirect
0	No	4	X	Indirect
41,414	No	4	X	Indirect
40,420	No	4	S	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect

Footnotes

Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.
Catalysta Ventures, LLC ("Catalysta") is under common control with Hatteras Venture Advisors III, LLC ("HVA III"). Catalysta is the general partner of Hatteras Venture Partners I, LP ("HVP I"). The securities held directly by HVP I are indirectly held by Catalysta, which may be deemed to share voting and dispositive power with regard to the securities directly held by HVP I. Catalysta disclaims beneficial ownership of the securities held by HVP I except to the extent of its pecuniary interest therein. The individual managers of Catalysta are Clay B. Thorp and John Crumpler (the "Managers"), who may be deemed to share voting and dispositive power with regard to the securities held directly by Catalysta and HVP I. The Managers disclaim beneficial ownership of the securities held by Catalysta and HVP I except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.
HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.
Represents the net exercise of the warrants immediately prior to, and contingent upon, the closing of the Issuer's initial public offering.
The warrants were exercisable until, and were scheduled to expire upon, the closing of the Issuer's initial public offering.